CompaniesByCap
AXSM
Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare

Axsome Therapeutics, Inc. Cash Flow 2022–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014
Operating Activities
Operating Cash Flow-93.4M-128.4M-145.1M-116.5M-108.2M-78.5M-46.4M-30.1M-26.5M-21.3M-7.4M-4.6M
Depreciation & Amort.
Investing Activities
Capital Expenditure480,000270,000582,000702,000308,00045,89116,12132,6969,898104,56120,195
Free Cash Flow-93.9M-128.7M-145.7M-117.2M-108.5M-78.5M-46.4M-30.1M-26.5M-21.4M-7.5M
Financing Activities
Dividends Paid
Stock Buybacks

Axsome Therapeutics, Inc. Cash Flow — FAQ

Axsome Therapeutics, Inc. (AXSM) cash flow over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AXSM's cash flow history?

The chart and table above show Axsome Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.